Yifan Su

525 total citations
29 papers, 301 citations indexed

About

Yifan Su is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Yifan Su has authored 29 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Yifan Su's work include Polysaccharides and Plant Cell Walls (4 papers), Fungal Biology and Applications (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Yifan Su is often cited by papers focused on Polysaccharides and Plant Cell Walls (4 papers), Fungal Biology and Applications (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Yifan Su collaborates with scholars based in China, United States and Sweden. Yifan Su's co-authors include Ting Sun, Hua Tian, Guo‐Hui Fu, Qingqing Zhou, Dehui Li, Di Shi, Ping Wei, Baohua Yu, J Y Li and Teng Leng Ooi and has published in prestigious journals such as Journal of Clinical Oncology, Carbohydrate Polymers and Chemical Science.

In The Last Decade

Yifan Su

23 papers receiving 290 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yifan Su 116 66 50 48 33 29 301
Yahui Wang 150 1.3× 70 1.1× 52 1.0× 30 0.6× 19 0.6× 27 437
Bin-Bin Zhao 161 1.4× 74 1.1× 123 2.5× 34 0.7× 12 0.4× 19 374
Zifei Yin 212 1.8× 42 0.6× 37 0.7× 61 1.3× 59 1.8× 36 423
Simin Zhao 131 1.1× 71 1.1× 40 0.8× 50 1.0× 16 0.5× 26 370
Sang-Muk Oh 217 1.9× 42 0.6× 47 0.9× 30 0.6× 19 0.6× 10 362
Takehiro Hirano 227 2.0× 73 1.1× 49 1.0× 72 1.5× 17 0.5× 22 488
Yasuo Otsuka 78 0.7× 57 0.9× 93 1.9× 22 0.5× 26 0.8× 53 377
Zhiwei Miao 156 1.3× 40 0.6× 55 1.1× 56 1.2× 13 0.4× 32 357
Xiaogang Sun 180 1.6× 112 1.7× 37 0.7× 95 2.0× 26 0.8× 14 376

Countries citing papers authored by Yifan Su

Since Specialization
Citations

This map shows the geographic impact of Yifan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifan Su more than expected).

Fields of papers citing papers by Yifan Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifan Su. The network helps show where Yifan Su may publish in the future.

Co-authorship network of co-authors of Yifan Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yifan Su. A scholar is included among the top collaborators of Yifan Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifan Su. Yifan Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaobing, Qian Chen, Jie Jiao, et al.. (2025). Pb(Zr Ti1-)O3 single crystal growth and its miniature devices for medical high-frequency ultrasound imaging. Ceramics International. 51(24). 41212–41218.
2.
Feng, Mingxiao, M.K. Lei, Wan Luo, et al.. (2025). Structural feature and antitumor activity of a N-acetylglucosamine containing polysaccharide from Ganoderma sinense. Carbohydrate Polymers. 366. 123838–123838. 4 indexed citations
3.
Su, Yifan, Xiang Li, Joakim Andréasson, et al.. (2025). Tuning the photocaged spiropyran photoswitch with a sterically hindered adamantane group: releasing the stable merocyanine. Chemical Science. 16(48). 23121–23128.
6.
Su, Yifan, Qianyu Wang, Mingxiao Feng, et al.. (2024). A glucomannan from defatted Ganoderma lucidum spores: structural characterization and immunomodulatory activity via activating TLR4/MyD88/NF-κB signaling pathway. International Journal of Biological Macromolecules. 294. 139195–139195. 3 indexed citations
7.
Cao, Chao, et al.. (2024). Structural characterization of a galactoglucomannan with anti-neuroinflammatory activity from Ganoderma lucidum. Carbohydrate Polymers. 334. 122030–122030. 29 indexed citations
8.
Su, Yifan, et al.. (2024). Structural clarification of mannoglucan GSBP-2 from Ganoderma sinense and its effects on triple-negative breast cancer migration and invasion. International Journal of Biological Macromolecules. 269(Pt 1). 131903–131903. 6 indexed citations
9.
Su, Yifan, Chen Chen, Zi Ye, et al.. (2023). Prevalence of HIV Transmitted Drug Resistance in Nanjing from 2018 to 2021. Infection and Drug Resistance. Volume 16. 735–745. 3 indexed citations
10.
Su, Yifan, et al.. (2022). Facile production of tag-free recombinant human interleukin-11 by transforming into soluble expression in Escherichia coli. Protein Expression and Purification. 197. 106107–106107. 2 indexed citations
11.
Shi, Di, Lin Gao, Xiaochun Wan, et al.. (2022). Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China. BMC Medicine. 20(1). 483–483. 10 indexed citations
12.
Su, Yifan, Qianlan Yao, Yuyin Xu, et al.. (2021). Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions. Frontiers in Genetics. 12. 674094–674094. 13 indexed citations
13.
Li, Dehui, et al.. (2021). Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions. Breast Cancer Targets and Therapy. Volume 13. 725–742. 12 indexed citations
14.
Li, Dehui, et al.. (2020). A Network Pharmacology‐Based Identification Study on the Mechanism of Xiao‐Xu‐Ming Decoction for Cerebral Ischemic Stroke. Evidence-based Complementary and Alternative Medicine. 2020(1). 2507074–2507074. 12 indexed citations
15.
Zhou, Qingqing, et al.. (2020). Integrin β3 promotes cardiomyocyte proliferation and attenuates hypoxia-induced apoptosis via regulating the PTEN/Akt/mTOR and ERK1/2 pathways. International Journal of Biological Sciences. 16(4). 644–654. 67 indexed citations
16.
Su, Yifan, et al.. (2020). Compound Kushen Injection combined with Chemotherapy in Advanced Gastric Cancer. 108–112. 1 indexed citations
17.
Li, J Y, Ping Wei, Ye Guo, et al.. (2020). Clinical significance of circulating exosomal PD-L1 and soluble PD-L1 in extranodal NK/T-cell lymphoma, nasal-type.. American Journal of Cancer Research. 10(12). 4498–4512. 30 indexed citations
18.
Su, Yifan, et al.. (2018). Integrin β3 inhibits hypoxia-induced apoptosis in cardiomyocytes. Acta Biochimica et Biophysica Sinica. 50(7). 658–665. 15 indexed citations
19.
Ooi, Teng Leng, et al.. (2010). Binocular rivalry is affected by surface boundary contours. Journal of Vision. 5(8). 5–5.
20.
Wang, Jian‐Ping, et al.. (2009). [NF-kappa B activation in peripheral blood mononuclear cells of children with epilepsy].. PubMed. 11(1). 44–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026